Additionally, the positive correlation between ISG15 and hnRNPA2B1, coupled with their crucial roles in hypoxia‐induced malignant progression in BC, was validated in both BC cells and tissues, highlighting the potential of targeting hnRNPA2B1 ISGylation as a viable therapeutic approach for BC. Here, HNRNPA2B1 is linked to breast cancer.